Alternative Model to Transform a Funding Gap in Rare Disease Clinical Research
Frustrated that a promising therapy for a rare cancer was sitting in a freezer due to the lack of a relatively modest amount of funding, author Alexander Masters helped lead a campaign to crowd-fund a...
7 Apr 201636min
A New Economic Solution to Drive Cures to Patients
Generic drugs can be repurposed to create effective treatments in unsolved diseases. However, there is no economic incentive for industry to pay for a clinical validation and regulatory approval proce...
1 Apr 201650min
Partnering with Patients in the Development & Lifecycle of Medicines
Pharmatalk's Valerie Bowling welcomes Anton (Tony) Hoos, MD, PhD, Head of Medical, Amgen Europe and Marc Boutin, JD, Chief Executive Officer, National Health Council. We address how industry and pat...
21 Jan 201641min
Immuno-Oncology Drug Development: Challenges & Next Steps
PharmaTalk Radio's Valerie Bowling welcomes Immuno-Oncology 360° Co-Chair James Gulley, MD, PhD,National Cancer Institute as he leads a discussion with fellow Co-Chair, Axel Hoos, MD, PhD, GlaxoSmithK...
21 Des 201558min
Making Clinical Trials a Care Option for Patients: Piloting an Infrastructure
At Dpharm US 2015, Katherine Vandebelt, Global Head, Clinical Innovation, Eli Lilly hosted a talk show on MakingClinical Trials a Care Option for Patients to fantastic reviews. Valerie Bowling, produc...
7 Des 201546min
Safety Elements of Cancer Immunotherapies: Immune Related Adverse Events
In this episode of Pharma Talk Radio, we feature medical oncologist, Dr Anna Pavlick, Director of the Melanoma Program at the NYU Cancer Institute on Safety Elements of Cancer Immunotherapies. Dr Pavl...
10 Nov 201526min
How the Availability of Capital Impacts the Role of the CMO
At the May 2015 Chief Medical Officer’s Summit in Boston, we featured a session on: How the Availability of Capital Impacts the Role of the CMO In this session, the panelists cover: Optimal use of t...
19 Okt 201539min
How Investors Assess R&D Biotech Management
At the May 2015 Chief Medical Officer's Summit in Boston, we featured a session on: How Investors Assess R&D Biotech Management Take a look at the details below: In this session, we begin with a pre...
19 Okt 201550min
